The Red Cross and most blood banks do not automatically disqualify donors taking GLP-1 medications, though some facilities maintain their own screening criteria
The distinction matters for accurate risk assessment
2023, found increased risk for specific cancers including hematological, connective tissue, and pancreatic malignancies but no clear increased risk for prostate, hepatobiliary, or skin cancers, and mixed findings on breast cancer specifically
It is common for the FDA to require drug companies to conduct these types of post-marketing studies
TrimRx Mississippi streamlines the process with a digital consultation, approval, and home delivery of compounded semaglutide or semaglutide shots
The FTO rs9939609 variant relates to appetite regulation and may correlate with side-effect tolerance